ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,285.34
0.47%
Dow Jones
38,758.34
-0.13%
Gold vs US Dollar
2,372.615
0.75%
Brent Oil
79.775
1.55%
Bitcoin
70,879.01
-0.28%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pacira BioSciences Inc (PCRX) Share Price

PCRX Pacira BioSciences Inc

29.285
-0.875 (-2.90%)
Last Updated: 18:58:47
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Pacira BioSciences Inc NASDAQ:PCRX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.875 -2.90 29.285 29.27 29.30 30.39 29.18 30.1 168,860 17:58:47   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 678.4M 41.96M 0.9022 32.42 1.36B
 Type  Size  Price  Time  Units 
 9 5 29.285 17:58:47 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore PCRX News
05/06/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
05/06/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
05/06/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
05/06/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
30/05/202413:00GLOBEPacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
14/05/202421:00EDGAR2Form 8-K - Current report
10/05/202412:00GLOBEPacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
Period
Draw mode
Data Downloads for PCRX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Pacira BioSciences Inc Articles